I
nterleukin-21 has structural homologies and functional similarities to the five other members of the common ␥-chain family of cytokines (IL-2, -4, -7, -9, and -15). IL-21 has substantial sequence and structural homology to IL-15 (1) . Moreover, the ␣-chain of the IL-21R is structurally similar to IL-2R␤, and also has sequence similarity to IL-2R␤ and IL-4R␣ (1, 2) . Like other members of the common ␥-chain family of cytokines, IL-21 was originally described as a growth factor for NK cells that can enhance the proliferation of TCR-stimulated T cells (1) . Soon thereafter, this cytokine was shown to have diverse effects both on B and dendritic cells. IL-21R Ϫ/Ϫ mice were shown to have low concentrations of IgG1 and high concentrations of IgE in their serum (3); IL-4 Ϫ/Ϫ
IL-21R
Ϫ/Ϫ mice were shown to have dysregulated Ab class switching, including an absence of IgE (4) . In addition, other investigators have shown that IL-21 may exert suppressive effects on dendritic cells (5, 6) . Interestingly, the effects of IL-21 are determined, at least in part, by the state of differentiation of its target cells.
In light of the importance of IL-2 and IL-15 in CD8 ϩ T cell biology, the role of IL-21 in CD8 ϩ T cell differentiation and function has been an area of particular interest. Kasaian et al. (3) demonstrated that IL-21 could enhance proliferation of T cells costimulated with anti-CD3 Abs as well as enhance T cell proliferation, cytotoxicity, and IFN-␥ release in response to alloantigen. IL-21 has been shown to stimulate Ag-dependent proliferation of human CMV-specific CD8 ϩ T cells (7, 8) . Recent in vivo studies indicate that IL-21 may induce tumor rejection through a CD8 ϩ T cell-dependent mechanism (9, 10) . This cytokine has also been shown to enhance CD8 ϩ T cell functional activities such as cytokine secretion, proliferation, and cytotoxicity when administered in combination with IL-15 (3, (11) (12) (13) (14) . Because many of the documented IL-21-mediated effects on CD8 ϩ T cells overlap with the activities of IL-2 and IL-15, some investigators have suggested that IL-2 and IL-21 may have redundant roles in T cell development and function (15) .
In the present study, we examined the role of IL-21 on Agspecific CD8 ϩ T cells. We found that IL-21, like other common ␥-chain cytokines, can stimulate the proliferation and function of these cells. However, we also found that IL-21 has a unique ability to drive these cells to apoptosis.
Materials and Methods

Animals
Naive and SIV-vaccinated rhesus monkeys were used in this study. Two monkeys that expressed the MHC class I molecule Mamu-A*01 were vaccinated with HIV-1 89.6P env and SIVmac239 gag-pol-nef DNA vaccines on weeks 0, 4, and 8 (AW28 and AW2P), and two other Mamu-A*01 ϩ monkeys were vaccinated with the recombinant adenoviruses AdV5-SIV gag-pol and AdV5-HIV-1 89.6P env on weeks 0 and 8 (AW13 and AV83) (16) . These animals were maintained in accordance with the guidelines of the Committee on Animals for the Harvard Medical School and the Guide for the Care and Use of Laboratory Animals.
Recombinant human cytokines
Human recombinant IL-2 manufactured by Hoffmann-La Roche was obtained from the National Institutes of Health AIDS Research and Reference Reagent Program (Product No. 136; Lot No. R163990-1). Recombinant human IL-21 produced in Escherichia coli was provided by ZymoGenetics.
[ 3 H]Thymidine incorporation assays
PBMCs were isolated from normal human volunteers or naive rhesus monkeys from EDTA-anticoagulated blood by Ficoll density gradient centrifugation. PBMCs were cultured at 37°C at 1 ϫ 10 6 cells/ml in RPMI 1640 supplemented with L-glutamine (2 mM), penicillin (50 U/ml), streptomycin (40 g/ml), and 8% FCS in triplicate wells for 3 days in 96-well plates precoated with plate-bound anti-CD3 Ab (anti-human CD3 Ab clone UCHT1; BD Pharmingen product no. 555330; anti-rhesus monkey CD3 Ab clone FN18 was generated in the laboratory). Twenty microliters of 50 Ci/ml [ 3 H]thymidine was added to each well 18 h before terminating the culture. Cells were harvested using an automated multiwell harvester, transferred to filter paper, and the filter paper was analyzed using a scintillation counter.
Abs, tetramers, and flow cytometry
Conjugated Abs used in this study included the following (product numbers shown after clones in parentheses were obtained from BD Biosciences, unless otherwise specified): anti-CD3 Pacific Blue (clone SP34.2; product no. 558124), anti-CD3 PerCP Cy 5.5 (clone SP34.2; product no. 552852), anti-CD3 Alexa 700 (clone SP34.2; product no. 557917), anti-CD3 allophycocyanin (clone SP34.2; product no. 557597), anti-CD3 allophycocyanin Cy7 (clone SP34.2; product no. 557757), anti-CD4 Amcyan (clone L200; custom conjugate from BD Biosciences), anti-CD4 PerCP Cy5.5 (clone L200; product no. 552838), anti-CD8 Pacific Blue (clone RPA-T8; product no. 558207), anti-CD8 FITC (clone SK1; product no. 347313), anti-CD8 PerCP Cy5.5 (clone SK1; product no. 341051), anti-CD8 energy-coupled dye (clone 7PT3F9, generated in the laboratory and custom conjugated by Beckman Coulter), anti-CD8 Alexa 700 (clone RPA-T8; product no. 557945), anti-CD25 PE (clone M-A251; product no. 555432), anti-IFN-␥ allophycocyanin (clone B27; product no. 554702), anti-phospho-Stat5 (Y694) PE (clone 47; product no. 612567), antiphospho-Stat3 (Y705) PE (clone 4; product no. 612569), and anti-Bcl-2 FITC (clone Bcl-2/100; product no. 65114X). Recombinant human annexin V allophycocyanin (AnnexinV05; Caltag Laboratories) was used. p11C-Mamu A*01 tetrameric complexes were generated and conjugated to PE or PE-Cy7. Purified rabbit polyclonal anti-IL-21R␣ was purchased from Abcam (product no. ab13268). Purified IL-21R␣ was conjugated to PE using the Prozyme PhycoLink R-PE Conjugation kit (product no. PJ31K). All reagents were titrated on rhesus monkey PBMCs. Samples were evaluated using a FACSCalibur (BD Biosciences) or an LSR II instrument (BD Biosciences) and analyzed using FlowJo software (Tree Star).
Intracellular phosphoepitope flow cytometry
PBMCs were isolated from normal human volunteers or naive rhesus monkeys from EDTA-anticoagulated blood by Ficoll density gradient centrifugation. PBMCs were plated at 1 ϫ 10 6 cells/ml in RPMI 1640 supplemented with L-glutamine (2 mM), penicillin (50 U/ml), streptomycin (40 g/ml), and 12% FCS at 37°C and rested overnight. Cells were then stimulated with the indicated cytokines for 15 min at 37°C. Immediately after stimulation, cells were fixed for 15 min at 37°C in tissue-culture wells by adding an equal volume of 4% paraformaldehyde. Cells were then pelleted and resuspended in 1 ml of ice-cold 90% methanol and permeabilized overnight at Ϫ20°C. Following permeabilization, cells were washed four times with 3 ml of PBS, centrifuging at 4°C. Cells were then rehydrated in 1 ml of PBS/2% FCS for 1 h on ice, resuspended in 100 l of PBS/2% FCS and stained with anti-CD3 and anti-STAT Abs for 30 min on ice. Cells were then washed three times with PBS and analyzed on an LSR II flow cytometer (BD Biosciences). This protocol was adapted from the protocol presented in Ref. 17 .
Ag-specific T cell culture
PBMCs were cultured for 3 days at 4 ϫ 10 6 cells/ml with 10 g/ml p11C peptide (CTPYDINQM) in RPMI 1640 supplemented with L-glutamine (2 mM), penicillin (50 U/ml), streptomycin (40 g/ml), and 12% FCS. Cytokines were added as noted and cultures were maintained with half medium changes every other day.
Ab staining
Cultured cells were washed twice in PBS/2% FCS to remove medium and then resuspended in 100 l of PBS/2% FCS. Tetramers were incubated with the cells for 15 min, and then Abs were added and incubated for 10 additional min. Cells were then washed twice in PBS/2% FCS and then fixed with 1% formaldehyde before being analyzed by flow cytometry. When staining with annexin V in addition to the Abs, annexin binding buffer (BD Biosciences product no. 556454)/2% FCS was used in place of PBS/2% FCS, and annexin V was added to the mixture of Abs.
CFSE labeling
PBMCs were washed twice with HBSS, resuspended at 1 ϫ 10 7 cells/ml HBSS, and 1 M CFSE for 30 min at 37°C (Molecular Probes product no. C-1156), washed twice with RPMI 1640 containing 10% FCS to stop the staining reaction, and then cultured as described above.
Intracellular cytokine staining
Cultured cells were washed twice in PBS/2% FCS and resuspended in RPMI 1640/12% FCS medium containing (with BD Biosciences product numbers in parentheses): 5 g/ml of the peptide p11C (CTPYDINQM), monensin (product no. 554724), 1 g/ml anti-CD28 (product no. 555725), and 1 g/ml anti-CD49d (product no. 555501), and then incubated for 6 h at 37°C. Cultured cells were then washed twice and stained with tetramer for 15 min followed by staining for cell surface molecules for 10 additional min. After fixing and permeabilization with Cytofix/Cytoperm solution (product no. 554722), cells were washed with perm/wash buffer (product no. 554723) and stained with an Ab specific for IFN-␥. Cells were then washed in perm/wash buffer and fixed in 1% formaldehyde/PBS. Experimental cells were compared with cells in the absence of peptide and positive control cells incubated with 10 ng/ml PMA and 1 g/ml ionomycin.
TUNEL staining
Cultured cells were stained with tetramer and Abs as described above and then fixed in 1% paraformaldehyde on ice for 60 min. Cells were then washed twice with PBS and permeabilized overnight in 70% ethanol. Cells were then stained with reagents from the Apo-Direct Apoptosis kit (BD Biosciences product no. 556381). Briefly, permeabilized cells were washed twice with kit wash buffer and then stained in 50 l of staining solution containing 10 l of reaction buffer, 0.75 l of TdT, 5 l of FITC-dUTP, and 34.25 l of dH 2 0 for 60 min at 37°C. Stained cells were then washed twice with rinse buffer and resuspended in 1% paraformaldehyde. FITCdUTP fluorescence was compared with fluorescence seen in the positive and negative control cells included in the kit.
Intracellular Bcl-2 staining
Cultured cells were stained with tetramer and Abs as described above. Cells were then fixed and permeabilized by incubation for 30 min in Cytofix/Cytoperm (BD Biosciences product no. 554722). Cells were then washed twice in perm/wash buffer (BD product no. 554723) and stained with Abs specific for Bcl-2 for 30 min. Cells were finally washed twice with perm/wash buffer and fixed in 1% paraformaldehyde.
Results
Recombinant human IL-21 costimulates proliferation of rhesus monkey T lymphocytes
Previous work has demonstrated that IL-21, in combination with plate-bound anti-CD3, can costimulate the proliferation of murine thymocytes, mature murine T cells, and human CD45RA ϩ T lymphocytes (1). To characterize further the functional activity of IL-21, we evaluated the ability of recombinant human IL-21 to stimulate rhesus monkey and human peripheral blood T lymphocyte proliferation. As previously described, recombinant human IL-21 stimulated the proliferation of anti-CD3-exposed human PBMC in a dose-dependent fashion (Fig. 1A) . Moreover, no proliferation of these PBMCs was observed in response to IL-21 in the absence of anti-CD3 Ab. The efficiency with which IL-21 stimulated this proliferation was comparable to that of IL-2 stimulated proliferation, with 20 ng/ml IL-21 driving a level of proliferation comparable to 5 U/ml IL-2 and 80 ng/ml IL-21 driving a level of proliferation comparable to 20 U/ml IL-2. Like IL-2, recombinant human IL-21 also costimulated anti-CD3 Ab-exposed rhesus monkey PBMCs to proliferate in a dose-dependent fashion (Fig. 1B) . This observation indicated that we could explore the functional activities of recombinant human IL-21 in rhesus monkey lymphocyte populations.
Recombinant human IL-21 induces phosphorylation of STAT 3, but not STAT 5, in rhesus monkey T lymphocytes
Although IL-21 activates the same JAKs as other members of the common ␥-chain family of molecules (18 -22) , this cytokine has been reported to induce the activation of different STAT molecules. IL-2, IL-7, IL-9, and IL-15 primarily activate STAT 5A and STAT 5B (21, 23) , while IL-21 has been shown to induce the activation of STAT 1 and STAT 3 and smaller amounts of STAT 5A and STAT 5B in cell lines and mouse splenocytes (2, 18 -20) . To determine whether this is also true in monkey PBMCs, we assessed the levels of STAT 3 and STAT 5 phosphorylation in primary human and rhesus monkey PBMCs. PBMCs were stimulated for 15 min with 20 U/ml IL-2 or 20 ng/ml IL-21, stained to detect intracellular STAT 3 and STAT 5 phosphorylation, and subjected to flow cytometric analysis (17, 24) . As previously described, human T lymphocytes stimulated with recombinant human IL-2 demonstrated no up-regulation of phosphorylated STAT (pSTAT) 3 3 but expressed high levels of pSTAT 5 ( Fig. 2A) . Similarly, rhesus monkey T lymphocytes stimulated with recombinant human IL-2 showed no up-regulation of pSTAT 3 but expressed high levels of pSTAT 5 (Fig. 2B) . However, pSTAT 5 expression in IL-2-stimulated monkey T lymphocytes was lower than that seen in IL-2-stimulated human T cells. Consistent with previously published studies performed on cell lines and mouse splenocytes, primary human T lymphocytes stimulated with recombinant human IL-21 showed up-regulation of pSTAT 3 (Fig. 2C) . However, in contrast to what has been described in other reports, no up-regulation of pSTAT 5 was seen in IL-21-stimulated human T lymphocytes. pSTAT 3 was also up-regulated in rhesus monkey T lymphocytes stimulated with IL-21, while no change in pSTAT 5 levels was seen (Fig. 2D) . These data indicate that, although IL-2 and IL-21 share a common receptor chain and signal similarly through a JAK pathway, IL-2 and IL-21 initiate different STAT signaling. These two cytokines may therefore have different biological activities. Moreover, because recombinant human IL-21 had similar biologic activity in rhesus monkey and human cells, the monkey is a useful model for exploring IL-21 functional properties.
The IL-21R ␣-chain is expressed on Ag-specific memory CD8 ϩ
T cells
Defining the expression of the IL-21R on T lymphocytes is central to understanding the effect of IL-21 on the function of these cells. Investigators have demonstrated the expression of IL-21R␣ on Jurkat cells but were not able to demonstrate the expression of this receptor chain on other T cell lines including EL4 and K562 cells (1) . To examine whether IL-21R␣ is expressed on primary rhesus monkey T cells, an anti-IL-21R␣ Ab was conjugated to PE and used to stain rhesus monkey PBMCs in association with anti-CD3, -CD4, and -CD8 Abs. IL-21R␣ expression was clearly detectable on a subset of CD3 ϩ lymphocytes (Fig. 3A) . In fact, a higher percentage of CD3 ϩ lymphocytes expressed IL-21R␣ than did CD3 Ϫ lymphocytes. Moreover, IL-21R␣ expression was also detectable on a subset of CD3 ϩ CD4 ϩ and CD3 ϩ CD8 ϩ lymphocytes (Fig. 3, B and C) . Approximately twice as many CD8 ϩ as CD4 ϩ T cells expressed IL-21R␣. These data indicate that T cells are potentially important targets of IL-21.
We then determined whether IL-21R␣, like receptors for other cytokines in the common ␥-chain family, is expressed on Ag-specific CD8 ϩ T cells. PBMCs from three SIV Gag-vaccinated Mamu A*01 ϩ rhesus monkeys were stained with Abs specific for IL-21R␣, CD25, CD3, and CD8, as well as with a Mamu A*01/p11C tetramer to detect SIV Gag epitope-specific T cells. IL-21R␣ expression was higher on Ag-specific cells than on bulk CD8 ϩ cells from all monkeys studied (Fig. 3E) . Moreover, IL-21R␣ expression was comparable to the expression of CD25, the IL-2R␣ chain, a molecule expressed in the setting of T cell activation (Fig. 3D) . These data therefore suggest that Ag-specific T cells may be important targets of IL-21.
Ag-specific CD8 ϩ rhesus monkey T cells stimulated with IL-21 do not expand in culture
Because IL-21 drives the proliferation of Ag-stimulated CD8 ϩ T lymphocytes, we examined the expansion of this cell subpopulation in vitro following exposure to Ag and cytokine. Although IL-2 stimulated the expansion of Ag-specific CD8 ϩ T lymphocyte populations, IL-21 did not stimulate an increase in the number of these cells, quantitated either as percentage of total T cells (Fig. 4A) or as an absolute number of cells (Fig. 4B) . These findings were paradoxical, as we expected that a cytokine that induced T cell proliferation would also induce the expansion of a T cell population.
Recombinant human IL-21 can induce Ag-specific rhesus monkey CD8 ϩ T lymphocytes to proliferate and secrete IFN-␥
To further examine the effect of IL-21 on the function of these Ag-specific CD8 ϩ T cells, we assessed the proliferation of cytokine-exposed Ag-specific cells in response to peptide Ag to confirm that these cells could proliferate in response to IL-21. PBMCs from four SIV Gag-vaccinated Mamu A*01 ϩ rhesus monkeys were evaluated. PBMCs were cultured with the dominant epitope peptide p11C for 3 days and then cytokine was added. Although epitope peptide-stimulated PBMCs did not divide in the absence of exogenous cytokine (Fig. 5A) , they vigorously divided in the presence of IL-21 (Fig. 5C) . Moreover, this cell division was comparable to that stimulated by peptide and IL-2 (Fig. 5B) . Thus, Agspecific CD8 ϩ T cells proliferated following TCR triggering in the presence of IL-21.
To determine whether IL-21 also enhances effector function of Ag-specific CD8 ϩ T cells, PBMCs from an SIV Gag-vaccinated (AW13) rhesus monkey were cultured with the dominant epitope peptide p11C for 3 days, IL-2 or IL-21 was then added to the cultured cells, and IFN-␥ secretion by CD3 ϩ , CD8 ϩ , p11C tetramer-binding lymphocytes was measured by mAb staining and flow cytometric analysis 4 days later. Intracellular cytokine staining assays performed on the lymphocytes from the vaccinated monkey indicated that IL-21 increased epitope peptide-stimulated IFN-␥ secretion by the Ag-specific CD8 ϩ T cells (Fig. 5, D-F) . IL-2-stimulated Ag-specific CD8 ϩ T cells secreted more IFN-␥ than did IL-21-stimulated cells. This IFN-␥ secretion by CD3 ϩ
CD8
ϩ tetramernegative cells from the vaccinated monkey was also increased after culture with either IL-2 or IL-21. These data therefore indicate that IL-21 can increase CTL effector function. ϩ rhesus monkey AW28 were cultured with the dominant epitope peptide p11C for 3 days before the indicated concentrations of IL-2 or IL-21 were added. Ag-specific CD8 ϩ cells were enumerated both as percentage (A) and absolute number (B) on days 4, 7, and 11 following the addition of cytokine.
IL-21-stimulated Ag-specific CD8
ϩ T cells undergo apoptotic cell death T cells might proliferate but not expand in number in vitro following exposure to IL-21 because they might undergo apoptotic cell death. These in vitro-stimulated cells were therefore assessed by annexin V staining to determine whether IL-21-stimulated Agspecific CD8 ϩ T cells undergo apoptosis. On day 7, a higher fraction of tetramer ϩ CD8 ϩ T cells cultured in the presence of 20 ng/ml IL-21 bound annexin V than did those stimulated with no cytokine or with 20 U/ml IL-2 (Fig. 6, A and B) .
Because rapidly dividing cells can have unstable membranes and therefore bind annexin V (25-27), we also used a TUNEL assay to evaluate IL-21-stimulated Ag-specific CD8 ϩ T cells for apoptotic cell death. On day 7, more tetramer ϩ CD8 ϩ T cells ϩ T lymphocytes was determined on day 7 following addition of cytokine (A and B) . Percent TUNEL ϩ Ag-specific CD8 ϩ T lymphocytes from rhesus monkey AW13 was also determined on day 7 following addition of cytokine (C and D). Data are representative of two repetitions of an experiment done on PBMCs of four monkeys. cultured in the presence of IL-21 were TUNEL positive than those cells cultured in the presence of no cytokine or IL-2 (Fig. 6, C and  D) . These data therefore confirm that Ag-specific CD8 ϩ T cells stimulated in the presence of IL-21 undergo apoptotic cell death.
Ag-specific CD8
ϩ T cells stimulated with recombinant human IL-21 express lower levels of Bcl-2 than do Ag-specific CD8 ϩ
T cells stimulated with IL-2
This IL-21-induced proliferation and acquisition of effector function in association with an induction of apoptosis could be explained by various mechanisms. This cytokine may stimulate effector function but not deliver a concomitant survival signal, or it may directly stimulate apoptosis of certain cell subpopulations. To determine whether IL-21 was directly stimulating apoptosis or was leading to apoptosis because of the absence of a delivered survival signal, we examined the expression levels of the prosurvival protein Bcl-2 in these IL-21-exposed cells. PBMCs from four SIV Gag-vaccinated Mamu A*01 ϩ rhesus monkeys were cultured for 3 days with the dominant epitope peptide p11C, cytokine was added, and 11 days later, Bcl-2 expression was measured by mAb staining and flow cytometric analysis of CD3 ϩ , CD8 ϩ , p11C tetramerbinding lymphocytes. IL-2-stimulated Ag-specific CD8 ϩ T cells expressed higher levels of Bcl-2 than cells stimulated in the absence of cytokine (Fig. 7) . In contrast, IL-21-stimulated Ag-specific CD8 ϩ T cells expressed levels of Bcl-2 similar to or lower than those of cells cultured in the absence of cytokine (Fig. 7) . Similar observations were made in studies of these stimulated cell populations by Western blot analysis (data not shown). These data suggest either that IL-21-stimulated Ag-specific CD8
ϩ T cells lack a critical survival signal that is present in IL-2-stimulated Agspecific CD8
ϩ T cells or that IL-21 induces the expression of an upstream proapoptotic protein that results in the down-modulation of Bcl-2.
Discussion
We have confirmed in the present study that IL-21, like other common ␥-chain cytokines, can costimulate T cell proliferation and induce CD8 ϩ T cell secretion of IFN-␥. However, unlike other members of this family of cytokines, we have shown that IL-21 is unable to stimulate the growth and survival of Ag-specific CD8 ϩ T cell populations because it stimulates low levels of the prosurvival protein Bcl-2. These data therefore indicate that IL-21 has a unique role in CD8 ϩ T cell biology. This unexpected finding cannot be explained by technical problems encountered in the experiments. The assessment of the function of recombinant human cytokines on rhesus monkey cells should be valid, because thymidine incorporation and STAT signaling studies indicated that rhesus monkey and human cells behave comparably in response to recombinant human IL-21. Finally, we only examined the effects of IL-21 on vaccine-induced Ag-specific CD8 ϩ T cells. It has been shown that IL-21 has different effects on the same subpopulation of lymphocytes when the cells are in different stages of differentiation (9) . Other investigators who have examined the effect of IL-21 on CD8 ϩ T cells have seen somewhat different results. In one study, naive CD8 ϩ T cells specific for a tumor Ag were demonstrated to expand after 7 days in culture with no difference in annexin V binding (28) . In another study, it was demonstrated that IL-21 can expand tumor-specific CD8 ϩ T cells in vivo (11) . However, even if the proapoptotic effect of IL-21 is seen only in Ag-stimulated memory CD8 ϩ T cells, this would represent a key regulatory signal on a particularly important T cell subpopulation.
The present data suggest a new T cell-specific function for the common ␥-chain family of cytokines. The cytokines that use the common ␥-chain as a component of their receptor are generally thought of as growth factors (29 -32) . IL-2 is the only member of this cytokine family that has been previously associated with the induction of apoptosis and this was observed only in the activation-induced cell death pathway (32, 33) . However, IL-21 might be expected to have different functions than other members of the common ␥-chain family because it signals through different STAT molecules. It is possible that all apoptotic effects of the common ␥-chain family are mediated as a result of STAT 1 and/or STAT 3 signaling, because IL-2, the only other member of the family associated with apoptosis, has also been associated with low levels of STAT 1 and STAT 3 signaling (21, 23) . In fact, STAT 1 signaling has previously been associated with apoptosis (34, 35) .
The disparate effector functions observed in the present study highlight the important unresolved question of how the same JAK and similar STAT molecules can transduce signals that lead to very different consequences. These signaling differences may be explained by different configurations of the STAT molecules or by signaling through other pathways. A recent study explored the contributions of each of the tyrosine residues of the mouse IL-21R␣ molecule in stimulating STAT 1, STAT 3, and STAT 5 as well as the Shc-MAPK and Akt signal transduction pathways (2) . These data demonstrated that only one tyrosine (Y510) is important for optimal proliferation and stimulation of signaling pathways. It will be important to determine whether the other tyrosines are necessary for apoptosis, and which molecules transduce a signal between the tyrosine molecules and the apoptotic pathway.
Previous work has indicated that IL-21 can contribute to inducing apoptosis in B and NK cells when those cells are in certain stages of differentiation. IL-21 was shown to be proapoptotic in primary B cells and in B cells that are stimulated with LPS or anti-IgM Ab but not in B cells stimulated with anti-CD40 Ab (36 -38) . Similarly, NK cells stimulated with IL-21 were shown to undergo apoptosis (3, 39) . IL-21 can costimulate B cell proliferation, class switching, and Ab production after CD40 and cell surface IgM are cross-linked; however, it triggers apoptosis after B cell stimulation through TLR or cell surface IgM alone (1, 37, 38) . Similarly, IL-21 can induce NK cell cytotoxicity or proliferation, yet it induces apoptosis of NK cells that are in certain stages of differentiation (1, 3, 39, 40) . It is of interest to determine whether the differentiation status of CD8 ϩ T cells is important in determining whether IL-21 delivers a proapoptotic signal to CD8 ϩ T cells.
The precise role of Bcl-2 in IL-21-stimulated B cell apoptosis has been controversial. mRNA expression data suggested that Bcl-2 levels in IL-21-stimulated primary B cells can be reduced, leading to apoptosis (36) . However, this observation was not confirmed by other investigators who evaluated Bcl-2 protein levels in these stimulated cells (37) . In the present experiments, Bcl-2 protein levels in IL-2-stimulated Ag-specific CD8 ϩ T cells were substantially increased, while those in IL-21-stimulated Ag-specific CD8 ϩ T cells were comparable to those seen in Ag-specific CD8 ϩ T cells stimulated in the absence of cytokine. These data suggest that, while Bcl-2 levels do not differ significantly between IL-21-stimulated cells and cells stimulated in the absence of cytokine, low levels of Bcl-2 may be involved in IL-21-induced apoptosis.
We have also examined the stimulation of proapoptotic members of the Bcl-2 family of molecules in IL-21-stimulated Agspecific CD8 ϩ T cells. These studies suggested that IL-21-induced apoptosis of CD8 ϩ T cells may involve the proapoptotic BH3 family member Bid. Bid activation was demonstrated by intracellular flow cytometric staining on days 7 and 11 following the addition of cytokine to cultures of PBMCs, and on days 2 and 4 following the addition of cytokine to cultures of purified CD8 ϩ T cells. However, while findings were reproducible in experiments using cells from certain monkeys, they were not observed in cells of others of these outbred animals. The reason for the animal-to-animal variation is not clear. IL-21-induced apoptosis of CD8 ϩ T cells also differs from IL-21-induced B cell apoptosis in the novel cytokine's up-regulation of Bid rather than Bim (38) . Bim is downstream of growth-factor withdrawal pathways, while Bid is downstream of death-receptor or caspase pathways (41, 42) . Therefore, IL-21-induced CD8 ϩ T cell apoptosis may be an active process in which IL-21 directly stimulates CD8 ϩ T cells to die, while IL-21-stimulated B cells may undergo apoptosis after they proliferate without a concomitant survival signal.
These data raise the question of why it would be evolutionarily advantageous to have a cytokine that induces apoptosis of a differentiated, Ag-experienced CD8 ϩ T cell population. Some have suggested that this cytokine may down-regulate the innate immune response while enhancing the adaptive immune response, facilitating the transition from an innate to a pathogen-specific adaptive immune response. Others have proposed a model in which IL-21 is proapoptotic when lymphocytes are inappropriately or incompletely activated, providing a mechanism for preventing the development of autoimmune disease (9) . The data from the present study are consistent with this latter model and suggest that proper activation of primed Ag-specific CD8 ϩ T lymphocytes may require a further signal in addition to cytokine and Ag for proper activation.
Other hypotheses might also explain the ability of IL-21 to induce CD8 ϩ T cell apoptosis. IL-21 may be responsible for triggering the differentiation of lymphocytes to a short-lived effector population. CD8
ϩ T cells divide rapidly upon stimulation and most effector CD8 ϩ T cells undergo apoptosis (43) . Although IL-7
and IL-15 may drive lymphocytes to become long-lived memory populations (44) , IL-21 stimulation may drive them to become effector populations. Consistent with this hypothesis, the IL-7R␣ is preferentially expressed on Ag-specific CD8 ϩ T cells that are committed to become memory cells (45, 46) . This hypothesis is also consistent with data indicating that IL-21 production and receptor expression are dysregulated in NOD mice, potentially leading to the turnover of pathogenic T cells in these mice (10) . Alternatively, IL-21 could be a critical cytokine in the contraction phase of CD8 ϩ T cell differentiation. It is interesting to note that IL-21 is produced mainly by activated CD4 ϩ T cells, a cell population that peaks at approximately the same time as activated CD8 ϩ T cells. Activated CD4 ϩ T cells may produce IL-21 and this IL-21 may signal CD8 ϩ T cell populations to contract to avoid immunopathology.
